findmyKOL
Clinical trialNCT05626712RecruitingPhase 1/PHASE2Interventional

Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

SponsorCreative Medical Technology Holdings IncEnrollment18Diabetes Mellitus, Type 1Type 1 Diabetes
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The brief purpose of this research study is to learn about the safety and efficacy of intra-arterial administration of CELZ-201 in patients with newly diagnosed Type 1 Diabetes Mellitus (T1D).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Francesco Vendrame, MD

    University of Miami, Diabetes Research Institute

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Diabetes Research Institute, University of Miami Miller School of Medicine

    Miami, Florida, United States

    Francesco Vendrame, MDRodolfo Alejandro, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CELZ-201 Administration
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Apr 2023
Primary completion
31 Jan 2027
Completion
31 Jan 2028
Last update posted
19 Feb 2026
Registered enrollment
18
Registry id
NCT05626712
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.